Share
Did you like reading this story? Click the heart to show your love.
63
Latest News Employee Spotlight

Johnson & Johnson Leader Jennifer Taubert Named to Fortune's 2020 Most Powerful Women in Business List

Share
Did you like reading this story? Click the heart to show your love.
63
Taubert, who has helped guide the Janssen Pharmaceutical Companies of Johnson & Johnson during the COVID-19 pandemic, has been honored on the annual list for the fifth year in a row.
Today's Top Reads Close

The year 2020 has proven to be a challenging one, but it's also provided leaders the chance to really shine and support the companies—and the people—they serve in new and inspiring ways.

In tribute to her work as part of the Johnson & Johnson leadership team responsible for steering the company through an unprecedented year, Fortune has named Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals, to its Most Powerful Women in Business list for 2020.

Leading With Purpose in Uncertain Times


Each year since 1998, Fortune has highlighted 50 women who are at the top of their industries on its annual list, using four criteria: the size and importance of the woman’s business in the global economy, the health and direction of the business, the arc of the woman’s career, and her social and cultural influence.

This year, a new criterion was added: how the executive is wielding her power. In this moment of uncertainty with the pandemic, how is she using her influence to help shape her company and the wider world for the better?

Johnson & Johnson commends Taubert on this repeat recognition, which reflects her relentless commitment to the patients who rely on the company’s transformational medicines.

Share
Did you like reading this story? Click the heart to show your love.
63

Taubert, who has been honored for five years and moved up one spot on the list this year, heads the Janssen Pharmaceutical Companies of Johnson & Johnson. She leads the overall global strategy for the pharmaceuticals business, including overseeing the development of a Janssen investigational COVID-19 vaccine candidate and driving Janssen’s industry-leading portfolio, such as a new subcutaneous formulation of an existing medicine that reduces treatment time for patients living with multiple myeloma from several hours to three to five minutes.

She has also negotiated business deals to help improve the lives of patients with unmet medical needs, such as the recent acquisition of Momenta Pharmaceuticals, Inc.; fostered initiatives designed to ensure patient access and affordability; and served as a strong advocate for transparency in healthcare.

Johnson & Johnson commends Taubert on this repeat recognition, which reflects her relentless commitment to the patients who rely on the company’s transformational medicines.


Read about more ways the company is invested in supporting women as they work to help change the trajectory of health for humanity.

Did you like reading this story? Click the heart to show your love.
63

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue